Delivery of the Report will take 2-3 working days once order is placed.
Synopsis
Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered intravenously. It received final approval from the U.S. Food and Drug Administration on March 16, 2005, and gained approval in the European Union on April 25, 2008.Table of Contents
Related reports :
Enterprise Data Integration Company Regions Type Application Forecast
Moving Software Company Regions Type Application Forecast
Manufacturing Execution Software Company Regions Type Application Forecast
Issue Tracking Software Company Regions Type Application Forecast
Human Resource Software Company Regions Type Application Forecast
Environmental Software Company Regions Type Application Forecast
Endpoint Detection Response Edr Software Company Regions Type Application Forecast
Dropper Bottle Manufacturers Regions Type Application Forecast
Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details